U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07239089) titled 'Oucomes of Endovascular Atherectomy in Femoropopliteal Arterial Disease' on Nov. 16.
Brief Summary: Peripheral artery disease (PAD) affects >200 millionadults worldwide and is amajor cause of morbidity ranging from exertional lower extremity pain to ischemic rest pain and ulcer formation.
Endovascular treatment options for PAD have increased dramatically in the past several decades. The traditional endovascular treatment of severe PAD has been balloon angioplasty with or without adjunctive stenting.
The outcomes of balloon angioplasty and stenting are acceptable for short lesion lengths in the superficial femoral artery (SFA) and ...